These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 25280871)
1. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders. Yang Y; Jiang S; Yan J; Li Y; Xin Z; Lin Y; Qu Y Cytokine Growth Factor Rev; 2015 Feb; 26(1):47-57. PubMed ID: 25280871 [TBL] [Abstract][Full Text] [Related]
2. microRNAs and Neurodegenerative Diseases. Qiu L; Tan EK; Zeng L Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180 [TBL] [Abstract][Full Text] [Related]
4. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases. Zgorzynska E; Dziedzic B; Walczewska A Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501 [TBL] [Abstract][Full Text] [Related]
5. miRNAs as biomarkers of neurodegenerative disorders. Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293 [TBL] [Abstract][Full Text] [Related]
6. PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders. Lv J; Jiang S; Yang Z; Hu W; Wang Z; Li T; Yang Y Ageing Res Rev; 2018 Jul; 44():8-21. PubMed ID: 29580918 [TBL] [Abstract][Full Text] [Related]
7. Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases. Bai X; Bian Z; Zhang M Phytomedicine; 2023 Jan; 109():154582. PubMed ID: 36610130 [TBL] [Abstract][Full Text] [Related]
8. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases. Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826 [TBL] [Abstract][Full Text] [Related]
9. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases. Johnson DA; Johnson JA Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945 [TBL] [Abstract][Full Text] [Related]
10. Genes and the environment in neurodegeneration. Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001 [TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. Mariani E; Polidori MC; Cherubini A; Mecocci P J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338 [TBL] [Abstract][Full Text] [Related]
12. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis. Ciurea AV; Mohan AG; Covache-Busuioc RA; Costin HP; Glavan LA; Corlatescu AD; Saceleanu VM Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445986 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system. Petrucelli L; Dawson TM Ann Med; 2004; 36(4):315-20. PubMed ID: 15224658 [TBL] [Abstract][Full Text] [Related]
14. Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases. George M; Tharakan M; Culberson J; Reddy AP; Reddy PH Ageing Res Rev; 2022 Dec; 82():101756. PubMed ID: 36243357 [TBL] [Abstract][Full Text] [Related]
15. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis. Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814 [TBL] [Abstract][Full Text] [Related]
16. Nrf2 Weaves an Elaborate Network of Neuroprotection Against Stroke. Jiang S; Deng C; Lv J; Fan C; Hu W; Di S; Yan X; Ma Z; Liang Z; Yang Y Mol Neurobiol; 2017 Mar; 54(2):1440-1455. PubMed ID: 26846360 [TBL] [Abstract][Full Text] [Related]